NCT07687498

Brief Summary

This randomized, two-period, two-sequence crossover trial aims to evaluate the effects of intradialytic nutrition on dialysis adequacy, intradialytic hemodynamic parameters, and fatigue in adults receiving maintenance hemodialysis. Participants will receive standardized intradialytic nutrition during one study period and no food intake during the other period, with each participant serving as their own control. Dialysis adequacy will be assessed using the urea reduction ratio (URR) and single-pool Kt/V (spKt/V), while fatigue will be evaluated using the Piper Fatigue Scale. Intradialytic blood pressure and other clinical parameters will also be monitored throughout the study. The findings are expected to provide evidence regarding the safety and clinical effects of intradialytic nutrition and to support individualized nutritional management strategies for patients undergoing maintenance hemodialysis.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
36

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Apr 2022

Shorter than P25 for not_applicable

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 1, 2022

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 30, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 30, 2022

Completed
4 years until next milestone

First Submitted

Initial submission to the registry

June 26, 2026

Completed
11 days until next milestone

First Posted

Study publicly available on registry

July 7, 2026

Completed
Last Updated

July 7, 2026

Status Verified

July 1, 2026

Enrollment Period

3 months

First QC Date

June 26, 2026

Last Update Submit

July 1, 2026

Conditions

Keywords

HemodialysisNutritionFatigueUreaKinetics

Outcome Measures

Primary Outcomes (3)

  • Dialysis Adequacy (spKt/V)

    Dialysis adequacy was assessed using single-pool Kt/V (spKt/V)

    At the end of each 4-week study period.

  • Urea Reduction Ratio (URR)

    Urea Reduction Ratio (URR) calculated from routine pre- and post-dialysis blood samples.

    Assessed at the end of each 4-week study period.

  • Fatigue Severity

    Piper Fatigue Scale (22 items; total score 0-220). Higher scores indicate greater fatigue severity (worse fatigue).

    Assessed at the end of each 4-week study period.

Secondary Outcomes (2)

  • Intradialytic Systolic Blood Pressure

    During each dialysis session throughout each 4-week study period.

  • Intradialytic Diastolic Blood Pressure

    During each dialysis session throughout each 4-week study period.

Study Arms (2)

Standardized Intradialytic Nutrition

EXPERIMENTAL

Participants received a standardized renal meal during hemodialysis sessions.

Dietary Supplement: Standardized Intradialytic Nutrition

No Intradialytic Food Intake

NO INTERVENTION

Participants did not consume food during hemodialysis sessions.

Interventions

Participants received a standardized renal meal approximately 1.5 hours after the start of each hemodialysis session. The meal provided approximately 450 kcal and 20 g of protein and was designed according to renal dietary recommendations with low potassium and phosphorus content. Participants were instructed to consume the entire meal and not to consume any additional food during the dialysis session.

Standardized Intradialytic Nutrition

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Adults aged 18 years or older.
  • Receiving maintenance hemodialysis three times per week for at least 3 months.
  • Clinically stable.
  • Able to provide written informed consent.

You may not qualify if:

  • Active infection.
  • Hospitalization within the previous month.
  • Gastrointestinal disorders affecting oral intake.
  • Severe intradialytic hypotension requiring frequent intervention (MAP \<65 mmHg).
  • Cognitive impairment.
  • Pregnancy.
  • Scheduled kidney transplantation with an available donor during the study period.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Diamer Private Dialysis Center

Mersin, Yenişehir, 33343, Turkey (Türkiye)

Location

Mersin University, Faculty of Medicine Hospital, Hemodialysis Unit

Mersin, Yenişehir, 33343, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Kidney Failure, ChronicFatigue

Condition Hierarchy (Ancestors)

Renal Insufficiency, ChronicRenal InsufficiencyKidney DiseasesUrologic DiseasesFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesMale Urogenital DiseasesChronic DiseaseDisease AttributesPathologic ProcessesPathological Conditions, Signs and SymptomsSigns and Symptoms

Study Officials

  • Esra Köse, MSc

    Mersin University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
CROSSOVER
Model Details: Participants were randomized to one of two sequences in a two-period crossover design. Each participant received both interventions (standardized intradialytic nutrition and no intradialytic food intake) in different periods and served as his or her own control. Arm 1 Arm Title: Standardized Intradialytic Nutrition Arm Type: Experimental Description: Participants received a standardized renal meal during hemodialysis sessions. Intervention Type: Dietary Supplement (veya Other) Intervention Name: Standardized Intradialytic Nutrition Arm 2 Arm Title: No Intradialytic Food Intake Arm Type: No Intervention Description: Participants did not consume food during hemodialysis sessions. Intervention: (No Intervention)
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Profesör

Study Record Dates

First Submitted

June 26, 2026

First Posted

July 7, 2026

Study Start

April 1, 2022

Primary Completion

June 30, 2022

Study Completion

June 30, 2022

Last Updated

July 7, 2026

Record last verified: 2026-07

Data Sharing

IPD Sharing
Will not share

Individual participant data (IPD) will not be made publicly available because the study did not include a data-sharing plan in the informed consent process, and data contain confidential participant information.

Locations